3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
13
Active not recruiting
5
Not yet recruiting
3
Completed
2
Terminated
1
Suspended
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Breast Neoplasms
206
Neoplasms
191
Carcinoma, Non-Small-Cell Lung
91
Colorectal Neoplasms
89
Prostatic Neoplasms
78
Lung Neoplasms
73
Multiple Myeloma
49
Head and Neck Neoplasms
47
Melanoma
46
Pancreatic Neoplasms
43
Neoplasm Metastasis
42
Leukemia, Myeloid, Acute
41
Carcinoma, Hepatocellular
40
Recurrence
34
Brain Neoplasms
34
Squamous Cell Carcinoma of Head and Neck
33
Ovarian Neoplasms
31
Glioblastoma
29
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Glioma
27
Uterine Cervical Neoplasms
26
Sarcoma
26
Lymphoma, Non-Hodgkin
26
Lymphoma
26
Stomach Neoplasms
25
Lymphoma, Follicular
24
Carcinoma, Renal Cell
24
Esophageal Neoplasms
22
Colonic Neoplasms
22
Rectal Neoplasms
21
Interventions
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Uterine Neoplasms
×
90 days
×
Clear all
NCT03555422
2026-04-13
ENGOT-EN5
Karyopharm Therapeutics Inc
Phase 3
Completed
263 enrolled
NCT06662435
2026-03-23
GYNCOG
Northwestern University
Phase NA
Completed
60 enrolled